| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2a951edf88b333dc297c05ab491513bf |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-154 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-57423
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2008-05-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85e080e490b082f1eaa928471236b604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_416b194e0c6cd4c2680ee5caab49e503 |
| publicationDate |
2010-04-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20100036243-A |
| titleOfInvention |
Method for measuring progression time of non-small cell lung cancer after chemotherapy treatment based on thioredoxin expression |
| abstract |
The present invention provides chemotherapy treatment based on detecting an expression level of thioredoxin (TRX) in a biological sample of a patient or simultaneously detecting an expression level of thioredoxin and a methylation reaction state of a 14-3-3σ gene. The present invention relates to a method for predicting cancer progression time (TTP) in patients receiving NSCLC. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012125051-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2013089301-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2012067525-A1 |
| priorityDate |
2007-05-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |